Table 1.
Characteristics of viral vectors targeting T cells, macrophages, dendritic cells, hematopoietic stem cells for HIV-1 gene therapy1.
Gene therapy characteristics | Adenoviral vector | Lentiviral vector | Adeno-associated viral vector |
---|---|---|---|
Tissue tropism | proliferating and non-proliferating cells | proliferating and non-proliferating cells | proliferating and non-proliferating cells |
Packaging capacity | 7-35 kb | 8 kb | 4.5 kb |
Relative delivery efficiency | high | very high | high |
Gene expression level | transient | stable | stable or transient |
Integration site | 2N/A | random site | AAVS1 site in chromosome 19 |
Immunogenicity | high | low | negligible |
Pseudotyped with | Ad5/35 fiber | 3VSV- glycoprotein | 2N/A |
Receptors | CD46 | 4LDL receptor | Heparin sulfate proteoglycan (serotype 2) |
Table adapted from (Schroers et al. 2004; Zhang et al. 2013; Ayuso 2016; Summerford and Samulski 1998; Finkelshtein et al. 2013).
Not applicable.
Vesicular stomatitis virus.
Low density lipoprotein.